drugset / Trial / NCT03356795
Intervention of CAR-T Against Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cells immunotherapy in patients who have GD2, PSMA, Muc1, Mesothelin or other markers positive cervical cancer. Another goal of the study is to learn more about the persistence and function of CAR T cells in the body.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2029-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cervical cancer-specific CAR-T cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | Cervical cancer-specific CAR-T cells | Cell therapy | 1e+07 cells/kg | Intravenous |